CN1636070A - 编码一种g蛋白偶联受体的核酸及其用途 - Google Patents

编码一种g蛋白偶联受体的核酸及其用途 Download PDF

Info

Publication number
CN1636070A
CN1636070A CNA028265556A CN02826555A CN1636070A CN 1636070 A CN1636070 A CN 1636070A CN A028265556 A CNA028265556 A CN A028265556A CN 02826555 A CN02826555 A CN 02826555A CN 1636070 A CN1636070 A CN 1636070A
Authority
CN
China
Prior art keywords
gave18
nucleic acid
cell
dna
sequence
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Pending
Application number
CNA028265556A
Other languages
English (en)
Chinese (zh)
Inventor
H·埃辛德雷罗
蔡济东
S·J·布什
J·加森胡贝尔
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Aventis Pharmaceuticals Inc
Original Assignee
Aventis Pharmaceuticals Inc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Priority claimed from GBGB0206891.4A external-priority patent/GB0206891D0/en
Application filed by Aventis Pharmaceuticals Inc filed Critical Aventis Pharmaceuticals Inc
Publication of CN1636070A publication Critical patent/CN1636070A/zh
Pending legal-status Critical Current

Links

Images

Classifications

    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N15/00—Mutation or genetic engineering; DNA or RNA concerning genetic engineering, vectors, e.g. plasmids, or their isolation, preparation or purification; Use of hosts therefor
    • C12N15/09—Recombinant DNA-technology
    • C12N15/11—DNA or RNA fragments; Modified forms thereof; Non-coding nucleic acids having a biological activity
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • C07K14/705—Receptors; Cell surface antigens; Cell surface determinants
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P11/00—Drugs for disorders of the respiratory system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P11/00—Drugs for disorders of the respiratory system
    • A61P11/06—Antiasthmatics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P19/00—Drugs for skeletal disorders
    • A61P19/02—Drugs for skeletal disorders for joint disorders, e.g. arthritis, arthrosis
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y02—TECHNOLOGIES OR APPLICATIONS FOR MITIGATION OR ADAPTATION AGAINST CLIMATE CHANGE
    • Y02A—TECHNOLOGIES FOR ADAPTATION TO CLIMATE CHANGE
    • Y02A50/00—TECHNOLOGIES FOR ADAPTATION TO CLIMATE CHANGE in human health protection, e.g. against extreme weather
    • Y02A50/30—Against vector-borne diseases, e.g. mosquito-borne, fly-borne, tick-borne or waterborne diseases whose impact is exacerbated by climate change

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Engineering & Computer Science (AREA)
  • General Health & Medical Sciences (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Medicinal Chemistry (AREA)
  • Animal Behavior & Ethology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Genetics & Genomics (AREA)
  • Zoology (AREA)
  • Biomedical Technology (AREA)
  • Pulmonology (AREA)
  • Molecular Biology (AREA)
  • General Engineering & Computer Science (AREA)
  • Wood Science & Technology (AREA)
  • Biotechnology (AREA)
  • Rheumatology (AREA)
  • Immunology (AREA)
  • Biochemistry (AREA)
  • Biophysics (AREA)
  • Microbiology (AREA)
  • Physics & Mathematics (AREA)
  • Orthopedic Medicine & Surgery (AREA)
  • Physical Education & Sports Medicine (AREA)
  • Cell Biology (AREA)
  • Toxicology (AREA)
  • Pain & Pain Management (AREA)
  • Plant Pathology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Peptides Or Proteins (AREA)
  • Micro-Organisms Or Cultivation Processes Thereof (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
CNA028265556A 2001-11-13 2002-11-08 编码一种g蛋白偶联受体的核酸及其用途 Pending CN1636070A (zh)

Applications Claiming Priority (4)

Application Number Priority Date Filing Date Title
US35415001P 2001-11-13 2001-11-13
US60/354,150 2001-11-13
GB0206891.4 2002-03-22
GBGB0206891.4A GB0206891D0 (en) 2001-11-13 2002-03-22 A nucleic acid encoding a g-protein-coupled receptor and uses thereof

Publications (1)

Publication Number Publication Date
CN1636070A true CN1636070A (zh) 2005-07-06

Family

ID=26247015

Family Applications (1)

Application Number Title Priority Date Filing Date
CNA028265556A Pending CN1636070A (zh) 2001-11-13 2002-11-08 编码一种g蛋白偶联受体的核酸及其用途

Country Status (11)

Country Link
EP (1) EP1573028A2 (ru)
JP (1) JP2005515760A (ru)
KR (1) KR20050044461A (ru)
CN (1) CN1636070A (ru)
BR (1) BR0214118A (ru)
CA (1) CA2466521A1 (ru)
IL (1) IL161952A0 (ru)
MX (1) MXPA04004434A (ru)
NO (1) NO20042386L (ru)
RU (1) RU2004117891A (ru)
WO (1) WO2003042399A2 (ru)

Also Published As

Publication number Publication date
WO2003042399A2 (en) 2003-05-22
EP1573028A2 (en) 2005-09-14
KR20050044461A (ko) 2005-05-12
IL161952A0 (en) 2005-11-20
WO2003042399A8 (en) 2005-11-17
BR0214118A (pt) 2005-02-09
WO2003042399A9 (en) 2004-04-29
CA2466521A1 (en) 2003-05-22
JP2005515760A (ja) 2005-06-02
RU2004117891A (ru) 2005-03-27
MXPA04004434A (es) 2004-11-29
NO20042386L (no) 2004-06-08

Similar Documents

Publication Publication Date Title
CN1940068A (zh) 新的受体核酸及多肽
CN1211255A (zh) Ob受体及诊断和治疗体重疾病的方法
CN1575337A (zh) 哺乳动物细胞因子受体亚单位蛋白、相关试剂及方法
CN1444652A (zh) 哺乳动物受体蛋白;相关试剂和方法
CN1592625A (zh) G蛋白偶联受体测定
AU752043B2 (en) Spoil protein and nucleic acid molecules and uses therefor
CN1620466A (zh) 胱氨酸结折迭蛋白质
CN1372594A (zh) Ox2受体的同系物
CN1615439A (zh) 编码g蛋白偶联受体的基因及其使用方法
CN1195853C (zh) 神经营养因子nnt－1
CN101040186A (zh) 受体gpr86的用途
CN1642971A (zh) 编码g－蛋白质－偶联之受体的核酸及其用途
CN1636070A (zh) 编码一种g蛋白偶联受体的核酸及其用途
CN1382156A (zh) 与bcl－xl相互作用的多肽pablo及其有关用途
CN1813187A (zh) 编码g－蛋白质－偶联之受体的核酸及其用途
CN1898263A (zh) 编码新的前列腺素受体蛋白的核酸及其使用方法
CN1596269A (zh) 一种新型g蛋白偶联受体:gave10
CN1346368A (zh) 钾通道互作剂及其用途
US20020151046A1 (en) 52871, a novel human G protein coupled receptor and uses thereof
CA2318743A1 (en) Novel molecules of the tnf receptor superfamily and uses therefor
CN1714151A (zh) 新的谷氨酸受体调节蛋白和核酸分子及其用途
CN1498271A (zh) 钾通道相互作用蛋白及其用途
US6569667B1 (en) 26335, a novel human serine/threonine dehydratase and uses thereof
CN1169754A (zh) 人白介素-1受体辅助蛋白
US20030138418A1 (en) Nucleic acid encoding a G-protein-coupled receptor, and uses thereof

Legal Events

Date Code Title Description
C06 Publication
PB01 Publication
C10 Entry into substantive examination
SE01 Entry into force of request for substantive examination
C02 Deemed withdrawal of patent application after publication (patent law 2001)
WD01 Invention patent application deemed withdrawn after publication